Clinical Trial Update: Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) study evaluating biodistribution, metabolism, excretion, and brain uptake of the radiotracer 18F-JSS20-183A. The study targets tauopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tauopathies

Drugs mentioned

• 18F-JSS20-183A

Snippet

Sponsor: University of Pennsylvania | Conditions: Tauopathies | EARLY_Phase 1 | Status: RECRUITING